amlodipine and angiotensin ii

amlodipine has been researched along with angiotensin ii in 57 studies

Research

Studies (57)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.75)	18.7374
1990's	12 (21.05)	18.2507
2000's	30 (52.63)	29.6817
2010's	13 (22.81)	24.3611
2020's	1 (1.75)	2.80

Authors

Authors	Studies
Raij, L; Shultz, PJ	1
Beretta-Piccoli, C; Bühler, FR; Donati, L; Heinen, G; Kusch, F	1
Epstein, M; Fischetti, F; Horton, C; Loutzenhiser, RD	1
Bansal, V; Garg, P; Sagar, S; Singhal, PC	1
Elliott, HL	1
Elliott, HL; Howie, CA; Meredith, PA; Ueda, S	2
Bodin, F; Cardoni, O; Corea, L; Fogari, R; Innocenti, P; Meilenbrock, S; Porcellati, C; Provvidenza, M; Sullivan, J	1
Trimarco, B	1
Abe, J; Deguchi, J; Kurokawa, K; Makuuchi, M; Matsumoto, T; Noda, M; Ohno, M; Takuwa, N; Takuwa, Y	1
Hart-Favaloro, JL; Woodman, OL	1
Julius, S; Mann, J	1
Fukao, M; Hattori, Y; Kanno, M; Kitabatake, A; Okamoto, H; Sakuma, I; Sato, A; Tomioka, H; Watanabe, M	1
Anderson, TJ; Charbonneau, F; Elstein, E; Haber, H	1
Baumeler, HR; Cocco, G; Ettlin, T	1
Bescós, M; Campistol, JM; Campos, B; Iñigo, P; Lario, S; Oppenheimer, F; Piera, C; Rivera, F	1
Garcha, RS; Hughes, AD; Sever, PS	1
Liang, X; Su, M; Xie, X; Yu, G; Zhao, S	1
Díez, J; Fortuño, MA; González, A; Larman, M; López, B; Querejeta, R; Ravassa, S	1
Brosnan, MJ; Dominiczak, AF; Graham, D; Hamilton, CA; Jardine, E; Lygate, CA	1
Iwasaka, T; Masaki, H; Matsubara, H; Nishikawa, M; Nishiue, T; Shibasaki, Y	1
Draganov, B; Holdaas, H; Høieggen, A; Jenssen, T; Os, I; Stenehjem, A	1
Chen, J; Gu, Y; Lin, F; Lin, S; Ma, J; Yang, H; Zhu, W	1
Bernadet-Monrozies, P; Durand, D; Kamar, N; Rostaing, L	1
Berl, T; Drury, PL; Esmatjes, E; Goldhaber, SZ; Hricik, D; Hunsicker, LG; Lewis, EJ; Lewis, JB; Locatelli, F; Parikh, CR; Pfeffer, MA; Porush, JG; Raz, I; Rouleau, JL; Vanhille, P; Wiegmann, TB; Wolfe, BM	1
Bianchetti, MG; Edefonti, A; Fossali, E; Gartenmann, AC; Schmidtko, J; Simonetti, GD; von Vigier, RO	1
Gerzanich, V; Ivanova, S; Simard, JM	1
Ruilope, LM; Segura, J	1
Jaimes, EA; Raij, L; Zhou, MS	1
Faverdin, C; Marche, P; Polidano, E; Yin, X	1
Ioroi, T; Iwao, H; Izumi, Y; Izumiya, Y; Kim-Mitsuyama, S; Tanaka, T; Wanibuchi, H; Yamamoto, E; Zhan, Y	1
Siragy, HM; Webb, RL; Xue, C	1
Zoccali, C	1
Hasegawa, K; Hayashi, K; Homma, K; Itoh, H; Kimoto, M; Sugano, N; Tatematsu, S; Wakino, S; Yoshioka, K	1
Dong, YF; Ichijo, H; Kataoka, K; Kim-Mitsuyama, S; Matsuba, S; Ogawa, H; Shintaku, H; Tokutomi, Y; Yamamoto, E; Yamashita, T	1
Coletta, E; Leenen, FH; Ruzicka, M	1
Jaimes, EA; Pearse, DD; Puzis, L; Raij, L; Zhou, MS	1
Cao, G; Mastai, R; Mella, J; Muñoz, MC; Pereyra, L; Toblli, JE	1
Cao, T; Chen, X; Feng, X; He, H; Liu, D; Luo, Z; Ma, L; Tepel, M; Wang, L; Yan, Z; Yang, D; Zhu, Z	1
Aritomi, S; Enomoto, A; Koganei, H; Konda, T; Niinuma, K; Nitta, K; Ogawa, T	1
Akie, Y; Aritomi, S; Nakamura, Y; Nakayama, A; Satoh, Y; Sugiyama, A; Takahara, A; Wagatsuma, H	1
Hashimoto, T; Kanematsu, M; Kanematsu, Y; Kurihara, C; Liang, EI; Makino, H; Nuki, Y; Tsou, TL	1
Arakawa, K; Fujii, M; Inoki, I; Kimura, T; Konoshita, T; Makino, Y; Miyamori, I; Nakamura, H; Wakahara, S	1
Fujita, H; Harasawa, S; Hirayama, A; Koike, M; Kushiro, T; Nagao, K; Okubo, K; Otsuka, Y	1
Aritomi, S; Konda, T; Niinuma, K; Nitta, K; Ogawa, T	1
Bian, YF; Gao, F; Xiao, CS; Yang, HY; Yang, ZM; Zhang, NN	1
Lin, J; Lin, L; Peng, F; Tang, H	1
Aritomi, S; Harada, E; Hirano, K; Ishikawa, T; Kim-Mitsuyama, S; Kuwahara, K; Mori, Y; Nishida, M; Saiki, S; Sunggip, C	1
Do e, Z; Fukumoto, Y; Kanazawa, M; Matsumoto, Y; Sato, A; Satoh, K; Shimizu, T; Shimokawa, H; Takahashi, K	1
Balakrishnan, A; Cassis, LA; Charnigo, R; Chen, X; Daugherty, A; Howatt, DA; Moorleghen, JJ; Morris, AJ; Rateri, DL	1
He, DH; Lin, JX; Lin, LM; Ning, RB; Wang, HJ; Xu, CS; Zhang, LM	1
Cai, A; Feng, Y; Li, L; Mai, W; Qiu, R; Xu, R; Zheng, D; Zhou, Y	1
Boschmann, M; Dahlke, M; Danser, AHJ; Dole, WP; Engeli, S; Jordan, J; May, M; Nussberger, J; Pal, P; Prescott, MF; Stitah, S	1
Al-Abassi, FA; Al-Alsieni, AI; Anwar, F; Bacha, AO; Hejazi, MM; Kaleemuddin, M; Kazmi, I	1
Pathak, AS; Rojas, M; Stouffer, GA	1

Reviews

4 review(s) available for amlodipine and angiotensin ii

Article	Year
[Type 2 diabetes and nephropathy--new studies, new treatment strategies?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2002, Apr-10, Volume: 122, Issue:9 Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System	2002
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]. Presse medicale (Paris, France : 1983), 2002, Nov-09, Volume: 31, Issue:36 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Endothelins; Hemodynamics; Humans; Hypertension; Indoles; Irbesartan; Kidney; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Tetrazoles; Verapamil	2002
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence. Clinical therapeutics, 2003, Volume: 25, Issue:12 Topics: Albuminuria; Amlodipine; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Proteinuria; Tetrazoles	2003
Asymmetric dimethylarginine in end-stage renal disease patients: a biomarker modifiable by calcium blockade and angiotensin II antagonism? Kidney international, 2006, Volume: 70, Issue:12 Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Arginine; Biomarkers; Calcium; Calcium Channel Blockers; Humans; Kidney Failure, Chronic; Risk Factors; Tetrazoles; Valine; Valsartan	2006

Trials

15 trial(s) available for amlodipine and angiotensin ii

Article	Year
Long-acting calcium antagonists: amlodipine versus nifedipine gastrointestinal therapeutic system (GITS). Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1993, Volume: 11, Issue:5 Topics: Adult; Amlodipine; Angiotensin II; Blood Pressure; Delayed-Action Preparations; Digestive System; Double-Blind Method; Humans; Male; Nifedipine; Norepinephrine; Time Factors	1993
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine. Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:3 Topics: Adult; Aged; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Dizziness; Double-Blind Method; Drug Administration Schedule; Edema; Female; Headache; Humans; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan	1996
[The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension]. Cardiologia (Rome, Italy), 1995, Volume: 40, Issue:12 Suppl 1 Topics: Adult; Aged; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Italy; Losartan; Male; Middle Aged; Tetrazoles	1995
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood pressure, 1998, Volume: 7, Issue:3 Topics: Aged; Amlodipine; Angiotensin II; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Research Design; Risk Factors; Tetrazoles; Treatment Outcome; Valine; Valsartan	1998
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study) Journal of the American College of Cardiology, 2000, Volume: 35, Issue:1 Topics: Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Vasodilation	2000
The effect of amlodipine and enalapril on blood pressure and neurohumoral activation in hypertensive patients with Ribbing's disease (multiple epiphysal dystrophy). Clinical cardiology, 2000, Volume: 23, Issue:2 Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Enalapril; Heart Rate; Humans; Hypertension; Norepinephrine; Osteochondrodysplasias	2000
Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients. Journal of the American Society of Nephrology : JASN, 2001, Volume: 12, Issue:4 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Endothelin-1; Female; Hemodynamics; Humans; Kidney; Kidney Transplantation; Losartan; Male; Middle Aged; Renal Circulation; Renin; Transforming Growth Factor beta; Transforming Growth Factor beta1	2001
Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:1 Topics: Adult; Aged; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; Blood Pressure; Calcium Channel Blockers; Female; Heart Ventricles; Humans; Hypertension; Losartan; Male; Middle Aged; Myocardium; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptor, Angiotensin, Type 1	2002
Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease. Nephron, 2002, Volume: 90, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Echocardiography; Enalapril; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Renal Dialysis	2002
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Annals of internal medicine, 2003, Apr-01, Volume: 138, Issue:7 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Risk Factors; Tetrazoles; Treatment Outcome	2003
A comparative assessment of the duration of action of amlodipine and nifedipine GITS in normotensive subjects. British journal of clinical pharmacology, 1993, Volume: 36, Issue:6 Topics: Adult; Amlodipine; Angiotensin II; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Nifedipine; Norepinephrine; Vasodilator Agents	1993
Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood. Kidney international, 2003, Volume: 64, Issue:4 Topics: Adolescent; Albuminuria; Amlodipine; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Child; Creatinine; Cytoprotection; Female; Humans; Hypertension; Irbesartan; Kidney; Male; Serum Albumin; Tetrazoles	2003
Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients? American journal of hypertension, 2007, Volume: 20, Issue:11 Topics: Adult; Amlodipine; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Muscle, Skeletal; Norepinephrine; Quinapril; Renin; Sympathetic Nervous System; Tetrahydroisoquinolines	2007
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker. Journal of hypertension, 2010, Volume: 28, Issue:10 Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin I; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System	2010
Systemic and tissue-specific effects of aliskiren on the RAAS and carbohydrate/lipid metabolism in obese patients with hypertension. Journal of the American Society of Hypertension : JASH, 2017, Volume: 11, Issue:8 Topics: Adipose Tissue; Adult; Amides; Amlodipine; Angiotensin II; Antihypertensive Agents; Blood Glucose; Double-Blind Method; Female; Fumarates; Glucose; Humans; Hypertension; Insulin; Lipolysis; Male; Microdialysis; Middle Aged; Muscle, Skeletal; Obesity; Renin; Renin-Angiotensin System	2017

Other Studies

38 other study(ies) available for amlodipine and angiotensin ii

Article	Year
Effect of amlodipine on mesangial cell proliferation and protein synthesis. American journal of hypertension, 1992, Volume: 5, Issue:12 Pt 1 Topics: Amlodipine; Angiotensin II; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Endothelins; Glomerular Mesangium; Humans; Leucine; Platelet-Derived Growth Factor; Proteins; Thrombin; Thymidine; Tritium	1992
Antihypertensive mechanism of amlodipine in essential hypertension: role of pressor reactivity to norepinephrine and angiotensin II. Clinical pharmacology and therapeutics, 1992, Volume: 52, Issue:1 Topics: Adult; Amlodipine; Angiotensin II; Antihypertensive Agents; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Electrolytes; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nifedipine; Norepinephrine; Renin-Angiotensin System	1992
Effects of amlodipine on renal hemodynamics. The American journal of cardiology, 1989, Nov-07, Volume: 64, Issue:17 Topics: Amlodipine; Angiotensin II; Animals; Blood Vessels; Calcium Channel Blockers; Forecasting; Hemodynamics; In Vitro Techniques; Male; Microcirculation; Nifedipine; Perfusion; Potassium Chloride; Rats; Rats, Inbred Strains; Renal Circulation; Vasoconstriction	1989
Vasoactive agents modulate matrix metalloproteinase-2 activity by mesangial cells. The American journal of the medical sciences, 1995, Volume: 310, Issue:6 Topics: Amlodipine; Analysis of Variance; Angiotensin II; Animals; Calcium Channel Blockers; Cardiovascular Agents; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gelatinases; Glomerular Mesangium; Indomethacin; Matrix Metalloproteinase 2; Meclofenamic Acid; Metalloendopeptidases; Rats; Vasoconstrictor Agents; Vasodilator Agents	1995
Vascular reactivity: a measurement of calcium channel blockade. Journal of human hypertension, 1995, Volume: 9 Suppl 1 Topics: Amlodipine; Angiotensin II; Blood Pressure; Dihydropyridines; Humans; Infusions, Intravenous; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Vasoconstriction	1995
Stimulated activation of platelet-derived growth factor receptor in vivo in balloon-injured arteries: a link between angiotensin II and intimal thickening. Circulation, 1997, Sep-16, Volume: 96, Issue:6 Topics: Amlodipine; Angioplasty, Balloon; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Carotid Artery Injuries; Carotid Artery, Common; ErbB Receptors; Insulin Receptor Substrate Proteins; Male; Phosphoproteins; Phosphorylation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Platelet-Derived Growth Factor beta; Receptors, Angiotensin; Receptors, Platelet-Derived Growth Factor; Tetrazoles; Tunica Intima; Tyrosine	1997
Rabbit polymorphonuclear leukocytes release a factor that causes constriction of the coronary vasculature. The American journal of physiology, 1998, Volume: 275, Issue:4 Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amlodipine; Angiotensin II; Animals; Biological Factors; Bradykinin; Coronary Circulation; Female; Heart; In Vitro Techniques; Male; Neutrophils; Nitroprusside; Perfusion; Rabbits; Superoxides; Trypsin; Vasoconstriction	1998
Effect of prolonged treatment with amlodipine on enhanced vascular contractility in cardiomyopathic hamsters. Journal of cardiovascular pharmacology, 1999, Volume: 34, Issue:1 Topics: Actin Cytoskeleton; Amlodipine; Angiotensin II; Animals; Aorta; Calcium; Cardiomyopathies; Cricetinae; Dose-Response Relationship, Drug; Isometric Contraction; Mesenteric Arteries; Muscle, Smooth, Vascular; Phenylephrine; Potassium; Time Factors; Vasoconstriction; Vasodilator Agents	1999
Mechanism of action of angiotensin II in human isolated subcutaneous resistance arteries. British journal of pharmacology, 2001, Volume: 134, Issue:1 Topics: Amlodipine; Angiotensin II; Arteries; Benzimidazoles; Biphenyl Compounds; Calcium; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Flavonoids; Genistein; Humans; In Vitro Techniques; Nickel; Norepinephrine; Potassium; Ryanodine; Skin; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents	2001
Diverse effects of chronic treatment with losartan, fosinopril, and amlodipine on apoptosis, angiotensin II in the left ventricle of hypertensive rats. International journal of cardiology, 2001, Volume: 81, Issue:2-3 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Blood Pressure; China; Disease Models, Animal; Fosinopril; Heart Ventricles; Hypertrophy, Left Ventricular; Losartan; Models, Cardiovascular; Myocardium; Random Allocation; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1	2001
Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats. Journal of hypertension, 2002, Volume: 20, Issue:2 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biological Availability; Biphenyl Compounds; Blood Pressure; Blood Vessels; Disease Models, Animal; Drug Therapy, Combination; Female; Hypertension; Immunohistochemistry; Irbesartan; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Nitric Oxide; Phosphoproteins; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Stroke; Superoxides; Tetrazoles	2002
[Diabetic patient with hypertension takes A-I I blocker. Less likely dialysis]. MMW Fortschritte der Medizin, 2002, Feb-21, Volume: 144, Issue:8 Topics: Albuminuria; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Diabetes Complications; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Risk Factors; Tetrazoles	2002
Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes. Chinese medical journal, 2002, Volume: 115, Issue:7 Topics: Amlodipine; Angiotensin II; Animals; Bosentan; Calcium Channel Blockers; Collagen Type IV; Diabetic Nephropathies; Drug Therapy, Combination; Endothelin Receptor Antagonists; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Summaries for patients. Effects of blood pressure drugs in patients with diabetes and kidney disease. Annals of internal medicine, 2003, Apr-01, Volume: 138, Issue:7 Topics: Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Hypertension; Irbesartan; Kidney Failure, Chronic; Male; Middle Aged; Placebos; Risk Factors; Tetrazoles; Treatment Outcome	2003
Early pathophysiological changes in cerebral vessels predisposing to stroke. Clinical hemorheology and microcirculation, 2003, Volume: 29, Issue:3-4 Topics: Amlodipine; Angiotensin II; Animals; Arterioles; Benzylamines; Brain; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; CREB-Binding Protein; Disease Susceptibility; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation; Hyperplasia; Hypertension; Models, Animal; Muscle, Smooth, Vascular; Nicotine; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nuclear Proteins; Oxidative Stress; Proliferating Cell Nuclear Antigen; Rats; Stroke; Sulfonamides; Trans-Activators	2003
Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. American journal of hypertension, 2004, Volume: 17, Issue:2 Topics: Amlodipine; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Endothelium-Dependent Relaxing Factors; Heart Ventricles; Hypertension; Isoprostanes; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E	2004
Role of L-type calcium channel blocking in epidermal growth factor receptor-independent activation of extracellular signal regulated kinase 1/2. Journal of hypertension, 2005, Volume: 23, Issue:2 Topics: Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cells, Cultured; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Activation; ErbB Receptors; Isradipine; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Thrombin; Verapamil	2005
Critical role of angiotensin II in excess salt-induced brain oxidative stress of stroke-prone spontaneously hypertensive rats. Stroke, 2005, Volume: 36, Issue:5 Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood-Brain Barrier; Calcium Channel Blockers; Cell Proliferation; Cerebral Arteries; Cerebral Cortex; Disease Models, Animal; Hippocampus; Hypertensive Encephalopathy; Male; Neurons; Oxidative Stress; Rats; Rats, Inbred SHR; Sodium Chloride; Stroke; Superoxides; Tetrazoles	2005
Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia. Journal of cardiovascular pharmacology, 2006, Volume: 47, Issue:5 Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Calcium Channel Blockers; Cyclic GMP; Drug Therapy, Combination; Gene Expression Regulation; Interleukin-6; Male; Myocardial Ischemia; NF-kappa B; Nitric Oxide; Rats; Rats, Inbred Lew; RNA, Messenger; Tumor Necrosis Factor-alpha	2006
Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circulation research, 2007, Jul-20, Volume: 101, Issue:2 Topics: Amidohydrolases; Amlodipine; Angiotensin II; Animals; Arginine; Blood Pressure; Coronary Circulation; Coronary Vessels; Creatine Kinase, MB Form; Enzyme Activation; Enzyme Inhibitors; Fibrosis; Heart Diseases; Imidazoles; Mice; Mice, Transgenic; Myocardium; Nitric Oxide; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Peptidyl-Dipeptidase A; Pyridines; Time Factors; Tunica Media; Up-Regulation; Vasodilator Agents	2007
Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure. Arteriosclerosis, thrombosis, and vascular biology, 2007, Volume: 27, Issue:12 Topics: Acetophenones; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Apoptosis; Biopterins; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Endothelium, Vascular; Heart Failure, Diastolic; Hydralazine; Hypertension; Male; MAP Kinase Kinase Kinase 5; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Nitric Oxide Synthase Type III; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium Chloride, Dietary; Superoxides; Tetrazoles; Time Factors; Valine; Valsartan; Vasodilation	2007
Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species. American journal of physiology. Renal physiology, 2008, Volume: 294, Issue:2 Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Gene Expression; Hypertension; Kidney Cortex; Kidney Medulla; Male; Membrane Proteins; Rats; Rats, Inbred Dahl; Reactive Oxygen Species; Sodium Chloride, Dietary; Spin Labels; Tetrazoles; Up-Regulation	2008
ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats. Obesity (Silver Spring, Md.), 2008, Volume: 16, Issue:4 Topics: Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Disease Models, Animal; Fatty Liver; Interleukin-6; Irbesartan; Liver; Liver Cirrhosis; Male; Metabolic Syndrome; Obesity; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha	2008
Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats. Hypertension (Dallas, Tex. : 1979), 2009, Volume: 53, Issue:1 Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Benzimidazoles; Benzoates; Blood Pressure; Calcium; Calcium Channel Blockers; Cells, Cultured; Gene Expression Regulation; Hypertension; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Telmisartan; TRPC Cation Channels; Vasoconstrictor Agents	2009
Different effects of L/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR/Izm. American journal of nephrology, 2009, Volume: 30, Issue:2 Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Conotoxins; Dihydropyridines; Humans; Male; Norepinephrine; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Time Factors	2009
Long-term blockade of L/N-type Ca(2+) channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart. British journal of pharmacology, 2009, Volume: 158, Issue:5 Topics: Action Potentials; Amlodipine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Atrioventricular Block; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, N-Type; Cardiomegaly; Chronic Disease; Dihydropyridines; Dogs; Electrocardiography; Epinephrine; Female; Male; Neurotransmitter Agents; Norepinephrine; Tetrazoles; Time Factors	2009
Pharmacologically induced thoracic and abdominal aortic aneurysms in mice. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:5 Topics: Aminopropionitrile; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Dissection; Blood Pressure; Desoxycorticosterone; Humans; Hypertension; Male; Mice; Mice, Inbred C57BL; Mineralocorticoids; Protein-Lysine 6-Oxidase	2010
Amlodipine suppressed cardiac gene expression of brain natriuretic peptide, transforming growth factor-β₁ and fibronectin mediated by aldosterone in male stroke-prone spontaneously hypertensive rats. The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:12 Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Fibronectins; Gene Expression Regulation; Heart; Hypertension; Male; Myocardium; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Transforming Growth Factor beta	2010
Effects of an N-type calcium antagonist on angiotensin II-renin feedback. American journal of nephrology, 2011, Volume: 33, Issue:2 Topics: Amlodipine; Angiotensin II; Animals; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Male; Models, Biological; Rats; Renin; Renin-Angiotensin System; Tetrazoles; Time Factors; Treatment Outcome; Valine; Valsartan	2011
Amlodipine treatment prevents angiotensin II-induced human umbilical vein endothelial cell apoptosis. Archives of medical research, 2011, Volume: 42, Issue:1 Topics: Amlodipine; Angiotensin II; Apoptosis; Calcium Channel Blockers; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Humans; Scavenger Receptors, Class E; Umbilical Veins; Vasoconstrictor Agents	2011
Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection. International journal of molecular medicine, 2012, Volume: 30, Issue:6 Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Cardiotonic Agents; Collagen; Gene Expression Regulation; Heart Ventricles; Hypertension; Hypertrophy, Left Ventricular; Kidney; Losartan; Male; Natriuretic Peptide, Brain; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stroke Volume; Transforming Growth Factor beta1; Ultrasonography	2012
Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice. Biochemical and biophysical research communications, 2013, May-03, Volume: 434, Issue:2 Topics: Amlodipine; Angiotensin II; Animals; Aorta, Thoracic; Biomarkers; Blood Pressure; Calcium; Calcium Channel Blockers; Calcium Channels, N-Type; Dihydropyridines; Dose-Response Relationship, Drug; Endothelium, Vascular; Hemodynamics; Hypertension; Macrophages; Mice; omega-Conotoxin GVIA; Oxidative Stress; Reactive Oxygen Species; Vasodilation; Vasodilator Agents	2013
Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation. PloS one, 2013, Volume: 8, Issue:8 Topics: Amlodipine; Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apoptosis; Atorvastatin; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Drug Therapy, Combination; Enzyme Activation; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Lipids; Male; Matrix Metalloproteinases; Mice; Mice, Knockout; Pyrroles; rho-Associated Kinases	2013
Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. PloS one, 2013, Volume: 8, Issue:11 Topics: Amlodipine; Angiotensin II; Animals; Aortic Aneurysm; Atherosclerosis; Hyperlipoproteinemia Type II; Male; Mice; Mice, Knockout; Receptors, LDL	2013
Long-term prehypertension treatment with losartan effectively prevents brain damage and stroke in stroke-prone spontaneously hypertensive rats. International journal of molecular medicine, 2014, Volume: 33, Issue:2 Topics: Aldosterone; Amlodipine; Angiotensin II; Animals; Apoptosis; Blood Pressure; Brain; Hypertension; Losartan; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Prehypertension; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Stroke; Superoxide Dismutase; Time Factors	2014
Amlodipine suppresses Ang-II-induced endothelium dysfunction by diminishing ROCK1 expression. Clinical and experimental hypertension (New York, N.Y. : 1993), 2016, Volume: 38, Issue:2 Topics: Amlodipine; Angiotensin II; Apoptosis; bcl-2-Associated X Protein; Calcium Channel Blockers; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphoproteins; Proto-Oncogene Proteins c-bcl-2; rho-Associated Kinases; Vasoconstrictor Agents	2016
Alteration of serum immunoglobins, C-reactive protein, vitamin D, and electrolyte by atenolol and amlodipine in stress-induced hypertensive rats. Molecular and cellular biochemistry, 2018, Volume: 445, Issue:1-2 Topics: Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Atenolol; C-Reactive Protein; Calcium; Electrolytes; Female; Hypertension; Immunoglobulin G; Immunoglobulin M; Male; Potassium; Rats, Wistar; Sodium; Stress, Physiological; Vitamin D	2018
Expression of Cyr61 in ApoE Scientific reports, 2021, 02-11, Volume: 11, Issue:1 Topics: Amides; Amlodipine; Angiotensin II; Animals; Antihypertensive Agents; Apolipoproteins E; Blood Pressure; Cysteine-Rich Protein 61; Fumarates; Gene Expression Regulation; Humans; Hypertension; Irbesartan; Mice; Mice, Knockout; Renal Artery; Renal Artery Obstruction	2021